DURYSTA

BIMATOPROST · Allergan, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for DURYSTA, covering 2020-03-04 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)